Despite this inconsistency, which may reflect the effects of HORMAD1 depletion on cell cycle in differing contexts, it is clear from multiple studies that HORMAD1 expression in cancer positively associates with increased genomic instability and poor prognosis [14, 16, 19]. The gene discussed is HORMAD1; the disease is cancer.